KorrekturOpen Access · CC BY 4.0
Correction to “Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP”
MedComm · 2026-06 · 7 (6)
DOI: 10.1002/mco2.70757 ↗Kurz gefasst
Korrektur in der Zeitschrift MedComm, online erschienen am 29.05.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
[This corrects the article DOI: 10.1002/mco2.70715.].
Zitieren
APA
(2026). Correction to “Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP”. MedComm, 7(6). https://doi.org/10.1002/mco2.70757
Vancouver
Correction to “Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP”. MedComm. 2026;7(6). doi:10.1002/mco2.70757
BibTeX
@article{euvimed2026,
title = {Correction to “Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP”},
journal = {MedComm},
year = {2026},
volume = {7},
number = {6},
doi = {10.1002/mco2.70757}
}
EUVIMED